The potential benefit from the administration of exogenous Klotho in the context of infections from other known coronaviruses, such as MERS and SARS, should be evaluated in animal models, as the potential development of a therapeutic applicable to coronaviruses in general would be highly desirable for future pandemic preparedness. Here, KL is linked to infection.